He is likely not getting the offers he wants and BP or Big Diagnostics is not quite ready to sign without Bridge Study data. Better data, ICON master service agreement, access to LPC funding, and additional shares will allow Gerald to negotiate from a much stronger position.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links